Hydroxyacetic acid--2-hydroxypropanoic acid (1/1) → HCID 86741915, 화합물
반응식
[CH3:1][S:2]([OH:5])(=[O:4])=[O:3].[CH:6]1[CH:7]=[CH:8][C:9]([C:12]([OH:27])([C:21]2[CH:22]=[CH:23][CH:24]=[CH:25][CH:26]=2)[CH2:13][CH2:14][N:15]2[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]2)=[CH:10][CH:11]=1.[C:28](O)(=O)C(C)O.C(O)(=O)CO>ClCCl>[CH:6]1[CH:11]=[CH:10][C:9]([C:12]([OH:27])([C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)[CH2:13][CH2:14][N:15]2[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]2)=[CH:8][CH:7]=1.[CH2:1]([S:2]([O-:5])(=[O:4])=[O:3])[CH3:28]참가 물질
4
실험 절차
In 3.0 ml of 30% gelatin (dissolved by warming) is dissolved 50 mg of pridinol methanesulfonate and the solution is added to 10 ml of a 30% dichloromethane solution of lactic acid-glycolic acid copolymer (78.1/21.9, average mol. wt. 10,000). The mixture is then worked up in the same manner as Example 1 to give pridinol ethanesulfonate microcapsules for injection.